NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-OD-20-095 from the NIH Guide for Grants and Contracts
Notice NOT-OD-20-098 from the NIH Guide for Grants and Contracts
Notice NOT-DE-20-019 from the NIH Guide for Grants and Contracts
Notice NOT-OD-20-099 from the NIH Guide for Grants and Contracts
Notice NOT-HL-20-740 from the NIH Guide for Grants and Contracts
Notice NOT-HL-20-739 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-20-170 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to advance surveillance science by supporting the development of new and innovative tools and methods for more efficient, detailed, timely, and accurate data collection by cancer registries. Specifically, the FOA seeks applications for projects to develop, adapt, apply, scale-up, and validate tools and methods to improve the collection and integration cancer registry data and to expand the data items collected. Applications must be built on partnership with U.S. population-based central cancer registries (a partnership must involve at least two different registries). Tools and methods proposed for development are expected to enhance the registry core infrastructure and, in so doing, expand the usefulness of registry-collected data to support high-quality cancer research.
Notice NOT-AR-21-006 from the NIH Guide for Grants and Contracts
Notice NOT-MD-20-020 from the NIH Guide for Grants and Contracts
Notice NOT-DA-20-050 from the NIH Guide for Grants and Contracts
Notice NOT-AR-20-018 from the NIH Guide for Grants and Contracts
Notice NOT-CA-20-051 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-AI-20-029 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications to participate in a clinical studies program to improve the long-term outcome of adult and pediatric transplant recipients (thoracic organ, abdominal organ, vascular composite tissue, and cellular replacement). The Clinical Trials in Organ Transplantation in Children and Adults (CTOT-CA) program will support cooperative, multi-institutional consortia for the conduct of interventional trials (Phase 1, 2, or 3) or observational clinical studies in organ, vascularized composite tissue, or cellular replacement allotransplantation. Each applicant institution must represent a consortium of 2 or more clinical sites. Each clinical study must include associated mechanistic studies that focus on immune-mediated processes that are relevant to the proposed clinical study. The goals of this research will be to further our understanding of and ultimately reduce immune- and infection-mediated morbidity and mortality of allotransplantation.
Funding Opportunity RFA-MH-20-500 from the NIH Guide for Grants and Contracts. NIMH seeks applications for pilot projects to evaluate the preliminary effectiveness of interventions targeting sustained and enhanced treatment response following acute treatment for anorexia nervosa (AN). An emphasis is placed on trials that go beyond seeking incremental gains in intervention effects, and instead take a theory-driven, empirical approach to developing and testing interventions that will have a significant impact on weight restoration and psychological symptoms associated with AN. Consistent with an effectiveness framework, studies should take a deployment-focused approach to intervention development and testing, acknowledging that many patients will receive post-acute treatment from community providers unaffiliated with specialty eating disorder centers.
Notice NOT-DE-20-020 from the NIH Guide for Grants and Contracts
Notice NOT-NS-20-048 from the NIH Guide for Grants and Contracts
Notice NOT-DA-20-048 from the NIH Guide for Grants and Contracts
Notice NOT-NS-20-047 from the NIH Guide for Grants and Contracts
Notice NOT-NS-20-049 from the NIH Guide for Grants and Contracts
Notice NOT-MH-20-040 from the NIH Guide for Grants and Contracts